AUS
NZ
UK
CA
USA
IND
Headlines
- Institutional investors continue adjusting their positions in Johnson & Johnson, reflecting ongoing portfolio strategies.
- State Street Corp and Geode Capital Management LLC increased their holdings, reinforcing engagement with the company.
- Market participants closely monitor ownership shifts to assess broader sector trends.
Institutional investors have made adjustments to their positions in Johnson & Johnson (NYSE:JNJ), a major player in the healthcare sector. The company operates in pharmaceuticals, medical devices, and consumer health products, maintaining a broad presence in the industry.
State Street Corp expanded its stake in Johnson & Johnson during the third quarter. The firm added to its holdings, reflecting a strategic approach to maintaining exposure within the healthcare industry. This adjustment aligns with a pattern observed among other investment firms over recent quarters.
Geode Capital Management LLC also increased its stake in the company. The firm has consistently maintained a presence in Johnson & Johnson, further solidifying its position. Adjustments in holdings among institutional investors suggest a continued focus on companies within the healthcare sector.
FMR LLC reported an increase in its position in Johnson & Johnson, maintaining alignment with its existing healthcare interests. The company remains a widely held asset among firms managing large-scale portfolios. The adjustments made by various firms indicate ongoing portfolio diversification efforts.
Charles Schwab Investment Management Inc. recorded an increase in shares held. This aligns with similar movements seen across other institutional investors. Portfolio adjustments in major healthcare companies continue to reflect broader sector trends.
Franklin Resources Inc. also expanded its holdings in Johnson & Johnson during the third quarter. The firm’s engagement with the company remains a component of its overall strategy within the healthcare sector. Institutional movements such as these provide insights into broader market behaviors.
Institutional investors and hedge funds collectively own a significant portion of Johnson & Johnson shares. Adjustments in ownership percentages among major firms indicate ongoing strategic shifts within the sector. These changes highlight evolving priorities among institutional market participants.
